Immunology

Omalizumab protects against early, late allergic responses

(HealthDay)—For patients with a significant response to allergen challenge, omalizumab induces protective effects against early (EAR) and late allergic reactions (LAR), according to a study published online June 5 in Allergy.

Neuroscience

Potential cause of Lafora disease revealed

Researchers at Okayama University report in the journal Matters, a potential third factor in the pathogenesis of Lafora disease. In addition to gene mutations, chemical modification of the enzyme Laforin induced by nitrosative ...

Diseases, Conditions, Syndromes

Study finds new pathways to treat non-alcoholic fatty-liver disease

Researchers from the University of South Carolina, Duke University, University of Alabama at Birmingham, and Metabolon Inc. Research Triangle Park have discovered a new pathway in the liver that opens the door to treat non-alcoholic ...

Diseases, Conditions, Syndromes

New compound targets TB bacterium's defense against the immune system

Part of the reason tuberculosis-causing bacteria are so good at colonizing the human body is that they have defenses against the body's immune system. A research team led by a Brown University chemist has developed a new ...

page 13 from 26